Trials / Conditions / Metastatic Ewing Sarcoma

Metastatic Ewing Sarcoma

7 registered clinical trials studyying Metastatic Ewing Sarcoma — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes NCT07194044	H. Lee Moffitt Cancer Center and Research Institute	Phase 1
Active Not Recruiting	Testing a New Combination of Anti-cancer Drugs in Patients Newly Diagnosed With Ewing Sarcoma Who Have Cancer NCT06820957	Children's Oncology Group	Phase 2 / Phase 3
Withdrawn	Lurbinectedin With or Without Irinotecan in Treating Patients With Relapsed or High Risk Metastatic Ewing Sarc NCT05042934	M.D. Anderson Cancer Center	Phase 1 / Phase 2
Completed	Indo-cyanine Green (ICG) in Paediatric Oncology MIS NCT04854018	Birmingham Women's and Children's NHS Foundation Trust	Phase 4
Active Not Recruiting	Cabozantinib S-malate in Treating Patients With Relapsed Osteosarcoma or Ewing Sarcoma NCT02243605	National Cancer Institute (NCI)	Phase 2
Active Not Recruiting	Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing NCT02306161	National Cancer Institute (NCI)	Phase 3
Completed	Intensity-Modulated Radiation Therapy in Treating Younger Patients With Lung Metastases NCT01586104	Ann & Robert H Lurie Children's Hospital of Chicago	N/A